Pharmacology Made Easy - Intro to Pharmacology
Fundamentals of Pharmacology and Medication Categories
Medication therapy is organized around nine body systems, alongside dedicated classifications for pain and inflammation, and infection:
Neurological system
Musculoskeletal system
Respiratory system
Cardiovascular system
Hematologic system
Gastrointestinal system
Reproductive system
Genitourinary system
Immune system
For each medication category, learning is structured around a central prototype medication, detailing:
Expected pharmacological action
Adverse drug reactions and interventions
Administration considerations
Client instructions
Contraindications and precautions
Medication interactions
Supportive learning tools include Quick Reference medication information tables, Safety Alerts, 10 drill questions per module, clinical case studies, and a 25-item practice test per module.
Neurological system medications are divided into central nervous system (CNS) and peripheral nervous system (PNS) agents. Central nervous system medication categories include:
Depressants
Stimulants
Anesthetics
Anticonvulsants
Treatments for neurodegenerative disorders
Psychotherapeutic medications
Medication Nomenclature and Legal Classifications
Generic Name: Official name assigned by the pharmaceutical company that develops the drug. A medication has only one generic name.
Brand / Trade Name: Proprietary name assigned by the commercial manufacturer marketing the medication. A single generic medication may have multiple brand names, which are capitalized.
Chemical Equivalence: Generic and brand-name medications share identical chemical compositions and have the same potential for abuse or dependence.
FDA Approval & Interchangeability: The U.S. Food and Drug Administration (FDA) conducts equivalence studies. Once therapeutic equivalence is established, generic forms are interchangeable with brand names, pending provider approval.
Prescription Medications: Drugs requiring supervision by a licensed health provider (physician, nurse practitioner, or physician's assistant) due to potential harm.
Ceftriaxone: Antibacterial antibiotic used for infections.
Captopril: Antihypertensive used for elevated blood pressure.
Diuretics: Medications that promote urination.
Fentanyl: Opiate-based narcotic analgesic for pain management.
Nonprescription (Over-the-Counter / OTC) Medications: Designated by the FDA as safe for use without medical supervision.
Examples: Acetaminophen, ibuprofen, diphenhydramine, loratadine, and cimetidine (Tagamet).
Pharmaceutics and Routes of Administration
Pharmaceutics governs how different medication forms affect dissolution, absorption rate, and onset of action.
Oral and Inhaled Medications
Forms: Tablets, capsules, powders, and liquids. Inhaled oral medications are typically in powder form.
Enteric-Coated Forms: Dissolve only after reaching the intestine to delay release and protect the stomach.
Extended-Release Forms: Release medication gradually over time; also termed extended length, sustained release, or sustained action.
Immediate-Release Forms: Expedite drug release immediately after swallowing.
Oral Disintegrating Tablets: Dissolve rapidly within the oral cavity.
Scored Tablets: Marked with a center line to allow equal splitting.
Crushing Rules: Tablets may be crushed if a client cannot swallow and liquid forms are unavailable. Extended-release, sustained-release, or capsule formulations must never be crushed.
Parenteral (Injectable) Medications
Administration Routes:
Intravenous (IV): Direct injection into a vein.
Subcutaneous (SubQ / sub): Injection into subcutaneous tissue.
Intramuscular (IM): Injection into muscle tissue.
Formulations: Supplied as liquid solutions or dry powders requiring reconstitution with liquid.
Absorption Dynamics:
Intravenous: Absorption is immediate and complete, resulting in an immediate onset of action.
Subcutaneous and Intramuscular: Absorption is variable. Rapid if the drug is highly water-soluble and tissue perfusion/blood flow is optimal; slow if the drug is poorly water-soluble or blood flow is impaired.
Topical and Transdermal Medications
Sites: Skin, eyes, ears, nose, rectum, vagina, or lungs.
Characteristics: Deliver a continuous dose over an extended duration, exhibiting a slower onset and longer duration of action compared to oral or parenteral routes.
Pharmacokinetics: Absorption, Distribution, Metabolism, and Excretion
Pharmacokinetics describes the movement of drugs through the body via four core processes (ADME):
Absorption
Definition: Movement of a medication from its site of administration into body tissues.
First-Pass Effect: Oral medications absorb through the intestinal wall into the portal vein and pass through the liver before reaching systemic circulation. Hepatic deactivation reduces the active drug amount available.
Bioavailability: The actual proportion of an oral medication that reaches systemic circulation following first-pass liver metabolism.
Bypassing First-Pass: Parenteral administration (IV, SubQ, IM) delivers drug directly into systemic circulation or blood vessels prior to reaching the liver.
Distribution
Definition: Transport of medication by the circulatory system to intended action sites.
Perfusion Dependent: Organs with rich blood supply (liver, kidneys, heart) receive the highest drug concentrations. Areas with poor supply (bones) or structural barriers (the brain's blood-brain barrier) receive significantly lower levels.
Metabolism (Biotransformation)
Definition: Chemical conversion of a medication into a more or less potent, more soluble, or inactive form (metabolite).
Primary Site: Liver.
Excretion
Definition: Elimination of medications or metabolites from the body.
Primary Route: Kidneys via urine (renal reabsorption may occur before final elimination).
Secondary Routes: Gastrointestinal tract, skin, and lungs.
Time-Action Concepts and Monitoring
Half-Life (t1/2): The time required for the total amount of medication in the body to decrease by 50%. Reflects efficiency of metabolism and excretion.
Short Half-Life: Requires multiple daily doses.
Long Half-Life: Administered once daily.
Organ Dysfunction: Hepatic or renal impairment reduces clearance, necessitating lower doses or prolonged dosing intervals to prevent drug accumulation.
Onset of Action: Elapsed time from administration to initial therapeutic response.
Peak Effect: Time required for a medication to achieve its maximum therapeutic effect.
Duration of Action: Length of time the therapeutic effect persists without additional doses.
Peak and Trough Serum Levels:
Peak Level: Highest serum concentration of the drug. Aligns with maximum therapeutic effect.
Trough Level: Lowest serum concentration of the drug.
Monitoring: Evaluated via timed laboratory blood draws to maintain continuous therapeutic levels (essential for drugs like antibiotics).
Pharmacodynamics, Receptor Dynamics, and Mechanism of Action
Pharmacodynamics encompasses the biochemical and physiological changes produced by a medication.
Cellular Mechanisms
Selective Medication Action: Selective drugs target specific receptors, producing narrow, targeted physiological effects. Non-selective drugs bind to widespread receptors, producing broader bodily reactions.
Agonists: Medications that bind to a receptor and trigger a greater than typical physiological response.
Antagonists: Medications that bind to a receptor to block or attenuate a response.
Competitive Antagonists: Compete directly with agonists for receptor sites. Higher doses of agonists can displace them, decreasing but rarely completely blocking the response.
Noncompetitive Antagonists: Block access to receptor sites regardless of agonist concentration. High doses can completely eliminate the agonist response.
Co-administration: Agonists and antagonists are sometimes prescribed together to maximize analgesia while mitigating opioid dependence.
Alterations of Cellular Environment
Penicillin-Type Antibiotics: Inhibit bacterial cell wall synthesis, causing cell destruction and death.
Sulfa-Type Antibiotics: Block folic acid utilization needed for bacterial DNA and RNA synthesis, inhibiting replication.
Antibiotic Mechanisms: Target bacterial cell wall synthesis, DNA synthesis, and RNA synthesis.
Expected Actions and Indications
Expected Pharmacologic Action: The specific biochemical action a drug exerts.
Indication: The clinical condition prompting administration (e.g., bacterial infection for antibiotics).
Multiple Therapeutic Uses Example (Diphenhydramine):
Antihistaminic Effect: Treats allergic responses.
Antiemetic Effect: Prevents motion sickness.
Sedative Effect: Hypnotic agent for insomnia.
Anticholinergic Effect: Used in Parkinson's disease treatment.
Adverse Drug Reactions, Safety Considerations, and Toxicity
Adverse Drug Reactions (ADRs)
Definition: Unintended, non-therapeutic effects occurring at therapeutic dosages.
Variability: Ranges from mild side effects (e.g., dry mouth, drowsiness) to severe life-threatening reactions.
Age-Specific ADRs (Diphenhydramine):
Older Adults: Confusion, uncoordination, dizziness, and convulsions.
Pediatrics: Hyperactivity and excitation.
Allergic Reactions and Anaphylaxis
Mild Allergic Reaction: Manifests as itching, rash, or hives. Re-exposure must be avoided due to sensitization risks.
Anaphylactic Shock: Massive immune reaction resulting in widespread release of histamine and inflammatory mediators.
Clinical Findings: Facial, ocular, oral, and pharyngeal edema; dyspnea, wheezing, tachycardia, and severe hypotension.
Emergency Interventions: Establish airway, administer oxygen, give Epinephrine (to elevate blood pressure and dilate bronchi), and administer Diphenhydramine (to block further histamine release).
Tolerance, Cumulative Effects, and Toxicity
Medication Tolerance: Decreased responsiveness over time, requiring dosage increases. Pharmacodynamic tolerance specifically describes long-term adaptation to opioid analgesics.
Dependence & Withdrawal: Physical or psychological need for a drug. Abrupt cessation causes specific physical and mental manifestations.
Cumulative Medication Effect: Drug accumulation occurring when hepatic or renal clearance is impaired, preventing full excretion before subsequent doses.
Medication Toxicity: Excessive drug concentration leading to organ damage.
Vancomycin: Causes permanent damage to cranial nerve VIII (8), leading to auditory deficits or total deafness.
Acetaminophen: Causes acute hepatic damage, potentially resulting in irreversible liver failure.
Precautions, Contraindications, and FDA Warnings
Precautions: Clinical considerations where benefits must outweigh potential risks. Requires physical assessments and lab monitoring (e.g., monitoring a stroke patient on anticoagulants who has active peptic ulcer disease to prevent gastric hemorrhage).
Boxed Warning: The strongest warning assigned by the FDA for medications with severe risk profiles. Example: Celecoxib carries a boxed warning for elevated cardiovascular events and severe gastrointestinal bleeding.
Contraindication: Absolute restriction precluding prescription of a drug due to dangerous or life-threatening adverse risks.
Drug-Drug and Drug-Food Interactions
Medication-Medication Interactions
Additive Effect (1 + 1 = 2): Combined effect of two drugs equals the sum of their individual effects (e.g., co-administering two CNS depressants leads to severe, potentially fatal respiratory and CNS depression).
Synergistic Effect (1 + 1 > 2): Combined effect is greater than individual effects (e.g., co-administering aspirin with warfarin intensifies anticoagulant action, causing severe hemorrhage).
Antagonistic Effect (1 + 1 < 2 / 1 + 1 = 0): One drug blocks or decreases the action of another (e.g., an airway-constricting cardiovascular drug opposing a bronchodilating asthma drug).
Medication-Food Interactions
Grapefruit Juice: Inhibits hepatic enzymatic metabolism, increasing drug concentration and toxicity risk. Interaction persists for hours after consumption. Must be avoided with:
Sertraline (Antidepressant)
Fexofenadine (Antihistamine)
Nifedipine (Calcium channel blocker)
Dietary Tyramine (Aged Wine, Processed Meats): Causes severe hypertensive crisis when combined with monoamine oxidase inhibitors such as Isocarboxazid or Tranylcypromine.
Dairy Products / Calcium: Binds to Tetracycline, preventing intestinal absorption.
High Vitamin K Foods (Dark Green Vegetables, Avocados, Spinach): Enhances synthesis of clotting factors, counteracting the anticoagulant effect of Warfarin.
High-Protein Meals: Decreases intestinal absorption of Levodopa, causing a sudden loss of therapeutic efficacy and exacerbation of Parkinson's symptoms.
Lifespan Considerations in Pharmacology
Pregnancy and Lactation
Placental Barrier: Medications and ingested foods cross the placenta via the umbilical cord.
Teratogenic Exposure: First-trimester exposure to teratogens causes structural fetal malformations.
Legacy FDA Categories: Categories A, B, C, D, and X (Category X demonstrated explicit evidence of fetal malformations).
Pregnancy and Lactation Labeling Rule (PLLR): Phased in from 2015 to 2020. Replaces letter categories with detailed narrative sub-sections: Pregnancy, Lactation, and Females and Males of Reproductive Potential.
Lactation: High milk drug concentrations, infant body size, and volume consumed dictate infant risk.
Pediatric Populations
Age Classifications:
Neonate: Less than 1 month of age (< 38 weeks gestation is classified as premature/preterm).
Infant: 1 month to 1 year of age.
Child: 1 year to 12 years of age.
Absorption Differences:
Gastric emptying is prolonged until 6 to 8 months of age.
Gastric pH remains higher (less acidic) until 2 years of age.
First-pass hepatic clearance is reduced.
Intramuscular absorption is delayed/erratic in neonates, but increased in infants and older children.
Distribution Differences: Total body water is higher and body fat is lower. The blood-brain barrier is immature in infants, allowing greater drug passage into CNS tissues.
Metabolism Differences: Hepatic enzyme production is reduced until 1 year of age. Metabolic rate increases significantly between 1 and 2 years of age, slowly declining thereafter until reaching adult levels at approximately 12 years of age.
Excretion Differences: Renal perfusion, glomerular filtration rate, and tubular resorption are reduced during the first year of life.
Dosing Requirements: Calculations must strictly adjust for age, body weight, and body surface area (BSA) to eliminate toxicity risks.
Older Adult Populations
Physiological Declines: Reduced cardiac output, decreased gastrointestinal peristalsis, elevated gastric pH, and decreased renal and hepatic function.
Clinical Management: Renal and hepatic laboratory evaluation is required prior to initiating therapy (e.g., assessing surgical hip fracture clients before administering anesthetics and postoperative analgesics).
Nursing Role in Client Education
Initiation: Begin medication instruction as early as possible following admission.
Essential Content: Drug purpose, generic and brand names, administration schedule, technique, potential ADRs, and precautions.
Pre-Assessment: Assess cognitive and developmental status, learning preferences, native language, and readiness to learn.
Adaptations: Utilize play-based learning approaches for pediatric clients. Employ professional medical interpreters for non-English speaking clients.
Instructional Modalities: Combine verbal instruction, written media (brochures/pamphlets), instructional videos, hands-on demonstrations, and verified internet resources.
Evaluation of Learning: Validate understanding using direct questioning, verbal repeat-backs, and return demonstrations for administration techniques (e.g., inhalers, injections).